Patents by Inventor Kenneth Edward Yelm
Kenneth Edward Yelm has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Publication number: 20200138764Abstract: Treatment for excess adipose tissue by applying an activating compound directly to a targeted area. The activating compound is a cyclohexanecarboxamide derivative. The activating compound promotes thermogenesis in cells to generate heat.Type: ApplicationFiled: November 7, 2019Publication date: May 7, 2020Inventors: Jose Mauro Goulart BRUM, Nicholas William GEARY, John Christian HAUGHT, Bhavani KASIBHATLA, Leo Timothy LAUGHLIN, II, Koti Tatachar SREEKRISHNA, John August WOS, Kenneth Edward YELM
-
Publication number: 20190330141Abstract: Personal care compositions, such as oral care and skin care compositions comprising one or more coolants. The pleasant cool sensation provided by a coolant is enhanced in terms of quicker onset, greater intensity, impact or longer duration, which improves appeal and acceptability of the compositions to consumers. Also, a treatment for excess adipose tissue by applying an activating compound directly to a targeted area.Type: ApplicationFiled: April 30, 2019Publication date: October 31, 2019Inventors: Gregory Mark Bunke, Heath A. Frederick, John Christian Haught, John August Wos, Kenneth Edward Yelm
-
Publication number: 20190276389Abstract: Personal care compositions, such as oral care and skin care compositions containing a flavor/perfume system comprising one or more coolants. The pleasant cool sensation provided by a coolant is enhanced in terms of quicker onset, greater intensity, impact or longer duration, which improves appeal and acceptability of the compositions to consumers.Type: ApplicationFiled: December 14, 2016Publication date: September 12, 2019Inventors: John August WOS, Kenneth Edward YELM, Gregory Mark BUNKE, Heath Alan FREDERICK, Michael REILLY, John Christian HAUGHT, Koti Tatachar SREEKRISHNA, Yakang LIN
-
Publication number: 20180312463Abstract: Synthesis methods to produce a series of carboxamides built off of an (S)-2-amino acid backbone or an (R)-2-amino acid backbone, depending upon the desired diastereomer of the end product.Type: ApplicationFiled: July 9, 2018Publication date: November 1, 2018Inventors: Kenneth Edward YELM, John August WOS, Gregory Mark BUNKE, Heath FREDERICK, John Christian HAUGHT, Steven Hamilton HOKE, Koti Tatachar SREEKRISHNA, Yakang LIN
-
Patent number: 9834740Abstract: Photoactivators comprise a photoactive moiety and a hydrophilic moiety. The photoactivators preferably comprise less than about 35%, by weight of the photoactivator, of the photoactive moiety. The photoactivators can be activated to a photo-excited state by excitation with incident radiation of a wavelength between about 350 nm and 750 nm, preferably between about 350 nm and about 420 nm. The photoactivators further encompass those having certain chemical formulations.Type: GrantFiled: January 12, 2015Date of Patent: December 5, 2017Assignee: The Procter & Gamble CompanyInventors: Alan David Willey, Jacob Robert Adams, Kady Lynn Willison, Kenneth Edward Yelm, Gregory Mark Bunke, Robb Richard Gardner
-
Publication number: 20170057911Abstract: Synthesis methods to produce a series of carboxamides built off of an (S)-2-amino acid backbone or an (R)-2-amino acid backbone, depending upon the desired diastereomer of the end product.Type: ApplicationFiled: October 21, 2016Publication date: March 2, 2017Inventors: Kenneth Edward YELM, John August WOS, Gregory Mark BUNKE, Heath FREDERICK, John Christian HAUGHT, Steven Hamilton HOKE, Koti Tatachar SREEKRISHNA, Yakang LIN
-
Publication number: 20150210963Abstract: Systems for treating a surface comprise a first composition and a second composition. The first composition comprises a water soluble organic photoactivator. The second composition comprises an electron acceptor which accepts an electron from the photoactivator when the photoactivator is in a photo-excited state and/or reduced state and a benefit active precursor which converts into a benefit active agent via electron transfer. Methods for treating a surface comprise applying the first composition to the surface, applying the second composition to the surface, and exposing the surface to light.Type: ApplicationFiled: January 12, 2015Publication date: July 30, 2015Inventors: Alan David Willey, Jacob Robert Adams, Kady Lynn Willison, Kenneth Edward Yelm, Gregory Mark Bunke, Robb Richard Gardner
-
Publication number: 20150210964Abstract: Consumer product compositions comprise a water soluble organic photoactivator, an electron acceptor which accepts an electron from the photoactivator when the photoactivator is in a photo-excited state and/or reduced state, and a benefit active precursor which converts into a benefit active agent via electron transfer. The electron acceptor is preferably not covalently linked to the photoactivator. Also disclosed are methods of making a benefit active, comprising exposing the consumer product compositions to light, preferably having a wavelength greater than about 350 nm.Type: ApplicationFiled: January 12, 2015Publication date: July 30, 2015Inventors: Alan David Willey, Jacob Robert Adams, Kady Lynn Willison, Kenneth Edward Yelm, Gregory Mark Bunke, William Richard Mueller, Robb Richard Gardner
-
Publication number: 20150210960Abstract: Photoactivators comprise a photoactive moiety and a hydrophilic moiety. The photoactivators preferably comprise less than about 35%, by weight of the photoactivator, of the photoactive moiety. The photoactivators can be activated to a photo-excited state by excitation with incident radiation of a wavelength between about 350 nm and 750 nm, preferably between about 350 nm and about 420 nm. The photoactivators further encompass those having certain chemical formulations.Type: ApplicationFiled: January 12, 2015Publication date: July 30, 2015Inventors: Alan David Willey, Jacob Robert Adams, Kady Lynn Willison, Kenneth Edward Yelm, Gregory Mark Bunke, Robb Richard Gardner
-
Publication number: 20140186272Abstract: The present invention provides synthetic routes for preparing various isomers of cyclohexane-based coolants, such as menthyl esters and menthanecarboxamide derivatives, in particular those substituted at the amide nitrogen, for example with an aromatic ring or aryl moiety. Such structures have high cooling potency and long lasting sensory effect, which make them useful in a wide variety of consumer products. One synthetic route involves a copper catalyzed coupling of a primary menthanecarboxamide with an aryl halide, such reaction working best in the presence of potassium phosphate and water. Using this synthetic route, specific isomers can be prepared including the menthanecarboxamide isomer having the same configuration as l-menthol and new isomers such as a neoisomer having opposite stereochemistry at the carboxamide (C-1) position. The neoisomer unexpectedly has potent and long lasting cooling effect.Type: ApplicationFiled: March 5, 2014Publication date: July 3, 2014Applicant: The Procter & Gamble CompanyInventors: Kenneth Edward YELM, Gregory Mark BUNKE, John Christian HAUGHT
-
Patent number: 8754259Abstract: The present invention provides synthetic routes for preparing various isomers of cyclohexane-based coolants, such as menthyl esters and menthanecarboxamide derivatives, in particular those substituted at the amide nitrogen, for example with an aromatic ring or aryl moiety. Such structures have high cooling potency and long lasting sensory effect, which make them useful in a wide variety of consumer products. One synthetic route involves a copper catalyzed coupling of a primary menthanecarboxamide with an aryl halide, such reaction working best in the presence of potassium phosphate and water. Using this synthetic route, specific isomers can be prepared including the menthanecarboxamide isomer having the same configuration as l-menthol and new isomers such as a neoisomer having opposite stereochemistry at the carboxamide (C-1) position. The neoisomer unexpectedly has potent and long lasting cooling effect.Type: GrantFiled: March 20, 2013Date of Patent: June 17, 2014Assignee: The Procter & Gamble CompanyInventors: Kenneth Edward Yelm, Gregory Mark Bunke, John Christian Haught
-
Patent number: 8748646Abstract: The present application relates to molecules comprising one or more beta-hydroxyamine moieties, for example, aminosilicones and compositions such as consumer products comprising such molecules, as well as processes for making and using such molecules and such compositions. The aforementioned process is safer, more efficient and thus more economical. Thus, the aforementioned moleculers may be more widely used.Type: GrantFiled: June 20, 2012Date of Patent: June 10, 2014Assignee: The Procter & Gamble CompanyInventors: Bernard William Kluesener, Robert Edward Shumate, Rajan Keshav Panandiker, Kenneth Edward Yelm
-
Patent number: 8426643Abstract: The present invention provides synthetic routes for preparing various isomers of cyclohexane-based coolants, such as menthyl esters and menthanecarboxamide derivatives, in particular those substituted at the amide nitrogen, for example with an aromatic ring or aryl moiety. Such structures have high cooling potency and long lasting sensory effect, which make them useful in a wide variety of consumer products. One synthetic route involves a copper catalyzed coupling of a primary menthanecarboxamide with an aryl halide, such reaction working best in the presence of potassium phosphate and water. Using this synthetic route, specific isomers can be prepared including the menthanecarboxamide isomer having the same configuration as l-menthol and new isomers such as a neoisomer having opposite stereochemistry at the carboxamide (C-1) position. The neoisomer unexpectedly has potent and long lasting cooling effect.Type: GrantFiled: August 14, 2009Date of Patent: April 23, 2013Assignee: The Procter & Gamble CompanyInventors: Kenneth Edward Yelm, Gregory Mark Bunke, John Christian Haught
-
Publication number: 20120323032Abstract: The present application relates to molecules comprising one or more beta-hydroxyamine moieties, for example, aminosilicones and compositions such as consumer products comprising such molecules, as well as processes for making and using such molecules and such compositions. The aforementioned process is safer, more efficient and thus more economical. Thus, the aforementioned moleculers may be more widely used.Type: ApplicationFiled: June 20, 2012Publication date: December 20, 2012Inventors: Bernard William KLUESENER, Robert Edward Shumate, Rajan Keshav Panandiker, Kenneth Edward Yelm
-
Publication number: 20100076080Abstract: The present invention provides synthetic routes for preparing various isomers of cyclohexane-based coolants, such as menthyl esters and menthanecarboxamide derivatives, in particular those substituted at the amide nitrogen, for example with an aromatic ring or aryl moiety. Such structures have high cooling potency and long lasting sensory effect, which make them useful in a wide variety of consumer products. One synthetic route involves a copper catalyzed coupling of a primary menthanecarboxamide with an aryl halide, such reaction working best in the presence of potassium phosphate and water. Using this synthetic route, specific isomers can be prepared including the menthanecarboxamide isomer having the same configuration as l-menthol and new isomers such as a neoisomer having opposite stereochemistry at the carboxamide (C-1) position. The neoisomer unexpectedly has potent and long lasting cooling effect.Type: ApplicationFiled: August 14, 2009Publication date: March 25, 2010Inventors: Kenneth Edward Yelm, Gregory Mark Bunke, John Christian Haught
-
Patent number: 5639746Abstract: The invention provides hydroxamic acid-containing compounds which are useful as inhibitors of matrix metalloproteases and which are effective in treating conditions associated with excess activity of these enzymes. In particular, the present invention relates to a compound having a structure according to Formula I ##STR1## wherein (A)R.sup.1, R.sup.2, R.sup.3, R.sup.4 and R.sup.5 are independently selected from various substituents; and(B) where R.sup.3 and R.sup.4 or R.sup.4 and R.sup.5 may together comprise a cyclic moiety; or a pharmaceutically-acceptable salt, biohydrolyzable amide or biohydrolyzable ester thereof.In other aspects, the invention is directed to pharmaceutical compositions containing the compounds of Formula (I), and to methods of treating diseases characterized by matrix metalloprotease activity using these compounds or the pharmaceutical compositions containing them.Type: GrantFiled: December 29, 1994Date of Patent: June 17, 1997Assignee: The Procter & Gamble CompanyInventor: Kenneth Edward Yelm